You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 10, October 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Low-Dose Continuous Insulin Therapy for Diabetic Ketoacidosis

Prospective Comparison With "Conventional" Insulin Therapy

David Heber, MD; Mark E. Molitch, MD; Mark A. Sperling, MD

Arch Intern Med. 1977;137(10):1377-1380.


Abstract

Low-dose insulin infusion has recently been used to treat ketoacidosis. We have prospectively compared patients with ketoacidosis either treated with insulin infusion at the rate of 6 units per hour or with high-dose, intermittent subcutaneously administered insulin, with emphasis placed on the hormonal responses. Basal glucagon, cortisol, and growth hormone levels were elevated in both groups. Cortisol and growth hormone levels did not fall with therapy in either group but glucagon levels fell in parallel with glucose levels in both groups. There was no difference in the time taken for glucose levels to fall below 250 mg/100 ml between groups. Whereas both methods of therapy appeared to be equally effective, low-dose infusion had the advantages of ease of administration, a predictable, relatively linear rate of fall of glucose levels, and ability to be stopped abruptly in the event of hypoglycemia.

(Arch Intern Med 137:1377-1380, 1977)



Author Affiliations

From the Division of Endocrinology and Metabolism, Departments of Medicine and Pediatrics, UCLA School of Medicine, Harbor General Hospital Campus, Torrance, Calif. Dr Molitch is now with the Division of Endocrinology and Metabolism, Tufts University-New England Medical Center Hospital, Boston.


Footnotes

Accepted for publication Nov 3, 1976.

Reprint requests to Division of Endocrinology and Metabolism, Tufts University-New England Medical Center Hospital, 171 Harrison Ave, Boston, MA 02111 (Dr Molitch).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of Hyperglycemic Crises in Patients With Diabetes
Kitabchi et al.
Diabetes Care 2001;24:131-153.
FULL TEXT  

Low- and High-Dose Intravenous Insulin Therapy for Diabetic Ketoacidosis
Gonzalez-Villalpando et al.
JAMA 1979;241:925-927.
ABSTRACT  

Diabetic Ketoacidosis: New Concepts and Trends in Pathogenesis and Treatment
KREISBERG
ANN INTERN MED 1978;88:681-695.
ABSTRACT  

Diabetic Ketoacidosis
Kumar et al.
Arch Intern Med 1978;138:660-660.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.